“La innovación digital ha permitido la generación, colección y almacenamiento de un gran volumen de datos relacionados con la salud que nos dan información del paciente”
David Lugo Palacios @dlugopal. Profesor Asistente. The London School of Hygiene and Tropical Medicine
Join the next GHECO seminar with Professor Matt Sutton. The session will explore the use of supply-demand interactions to estimate effects of population health interventions.
🗓️ Wednesday 2 October 2024
🕐 13:00 BST
▶️ https://t.co/W5N9vqAA9m
3) Previous target trial emulations have assumed no unobserved confounding. While we found that this is a plausible assumption amongst the RCT-eligible subpopulation, our results suggest that this assumption is likely implausible for the RCT-ineligible subpopulation
New @LSHTM_GHECO + @Basucally + @DrAmandaAdler + @karlado paper on @HECJournalTweet!
We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT
https://t.co/udjoOURUfz
2) We assess the performance of a local #IV approach vs a published RCT and explore essential heterogeneity across an entire target population, including subpopulations who met RCT eligibility criteria and those who did not
This research in @bmj_latest compared the effectiveness of three antidiabetic drugs for people with type 2 #diabetes mellitus.
SGLT-2 inhibitors were more effective second line treatments compared with DPP-4 inhibitors or sulfonylureas, @pbidulka
https://t.co/hl5dfHPWxh
New @LSHTM_GHECO paper on @bmj_latest ! We assessed the comparative effectiveness of 3 second line antidiabetics by emulating a target trial with #IVs and electronic health records
https://t.co/GT4AGbXBjF
Muy agradecido por la invitación de la @EGobiernoyTP para presentar un trabajo con colegas de @LSHTM_GHECO utilizando #targettrials y #LocalIV para estimar efectos de tratamiento heterogéneos
Hoy, @dlugopal, de @LSHTM, presentó estudio que muestra cómo los métodos de variable instrumental local (VIL) pueden proporcionar evidencia útil sobre la heterogeneidad del efecto de tratamientos médicos, incluyendo variables no observables.
#FormamosElFuturo
There are two vacancies in our team for health economists/data scientists/statisticians! Join us!! @LSHTM_GHECO
https://t.co/3E5eAyACqo
https://t.co/58vYHMg2wq
📢 @LSHTM is hiring two Research Fellows in #HealthEconomics/medical statistics/data science.
Join our vibrant team, working with leading health economists, clinicians & statisticians, to advance quants methods & answer major policy questions.
5 Feb ⏰ https://t.co/R06KkI7xjt
It's my very big pleasure to share the fantastic news that @lkovacevic1 has successfully passed her PhD viva earlier today! Congrats Dr Kovacevic! Massive thanks to @HealthEcon_Will and Brendan Delaney for examining and facilitating a really interesting discussion!!